Product
  • Product
  • Supplier
  • Inquiry

    EN

    Home > API > Antibiotics (Find 575 items)

    Antibiotics

    Natamycin

    (7681-93-8)
    Pimaricin is a macrocyclic tetraene originally isolated from Streptomyces natalensis in 1957. Pimaricin exhibits broad spectrum antifungal activity against yeast and filamentous fungi by binding specifically to ergosterol to block fungal growth. Unlike the related polyenes, nystatin and filipin, pimaricin does not change the permeability of the plasma membrane. Pimaricin is used in the food industry for surface treatment of cheeses as a mould inhibitor.

    Suppliers of Natamycin

    Request for quotation , get quotes from more suppliers.

    Oxytetracycline Hydrochloride

    (2058-46-0)
    Oxytetracycline hydrochloride is a salt prepared from oxytetracycline taking advantage of the basic dimethylamino group which protonates readily to form the salt in hydrochloric acid solutions. The hydrochloride is the preferred formulation for pharmaceutical applications. Like all tetracyclines, oxytetracycline shows broad spectrum antibacterial and antiprotozoan activity and acts by binding to the 30S and 50S ribosomal sub-units, blocking protein synthesis.

    Neomycin Sulfate

    (1405-10-3)
    NEOMYCIN SULFATE is an aminoglycoside antibiotic produced by S. fradiae that inhibits protein translation by binding to the small subunit of prokaryotic ribosomes. It blocks voltage-sensitive Ca2+ channels and is a potent inhibitor of skeletal muscle sarcoplasmic reticulum Ca2+ release. NEOMYCIN SULFATE has been shown to inhibit inositol phospholipid turnover, phospholipase C, and phosphatidylcholine-phospholipase D activity (IC50 = 65 μM). It is highly effective against Gram-positive and Gram-negative bacteria and is commonly used for the prevention of bacterial contamination of cell cultures.

    Azithromycin

    (83905-01-5)
    Semi-synthetic macrolide antibiotic; related to Erythromycin A. Antibacterial

    Gentamicin Sulfate

    (1405-41-0)
    Inhibits protein synthesis by binding to L6 protein of 50S ribosomal subunit. Antibacterial. Antibiotic complex consists of three closely related components, gentamicins C1, C2, C1a, and also gentamicin A which differs from the other members of the

    Lincomycin Hydrochloride

    (7179-49-9)
    1. An antibiotic produced by Streptomyces lincolnensis. Lincomycin is a lincosamide antibiotic that forms cross-links within the peptidyl transferase loop region of the 23S rRNA. Inhibits bacterial protein synthesis. Antibacterial.
    2. Antibacterial;Ribosomal protein synthesis inhibitor
    3. Lincomycin hydrochloride is a salt of lincomycin formed at the basic N-methylproline. The hydrochloride salt is the preferred formulation for pharmaceutical use. Lincomycin hydrochloride is a broad spectrum antibiotic with activity against anaerobic bacteria and protozoans. Lincomycin acts by binding to the 23S ribosomal subunit, blocking protein synthesis. Lincomycin has been extensively studied with over 7,000 literature citations.

    COLISTIM SULPHATE

    (1264-72-8)
    Cyclic polypeptide antibiotic produced by Bacillus polymyxa. Complex mixture of at least 30 components, primarily colistins A and B.[a]D= -65?(c= 1, Water) LOD: 3%

    Tilmicosin Phosphate

    (137330-13-3)
    Tilmicosin phosphate is a antibiotic, is used in veterinary medicine for the treatment of bovine respiratory disease and ovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica.
    Antibiotic refers to a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomyces) or higher animals and plants that have anti-pathogens or other activities during their life, and can interfere with the development of other living cells chemical material. With the widespread use and even abuse of antibiotics, antibiotic resistance is posing a threat to global health. Therefore, the development of new antibiotics is imperative, and based on different mechanisms of new antiviotics are at different stages of research and development. The rapid development of biotechnology has promoted the development of antibody drugs and antibacterial peptide drugs, and has become a new force in the field of antibiotics. The development is expected to provide a new way for the prevention and control of pathogenic microorganisms while solving antibiotic resistance. The "Echemi Antibiotics" list mainly supplies APIs for such drugs.
    Suggestions
    Email:
    Message:
    Send Message